Medtech Accelerator Sofinnova Md Start Iii Launches A Call For Early Stage Medical Device Projects
06/08/21, 4:23 PM
Location
paris
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today that its medtech accelerator, Sofinnova MD Start III, is launching a call for early-stage projects. Sofinnova MD Start III is part of the Sofinnova platform of funds and actively works with clinicians and entrepreneurs to develop disruptive therapeutic medical devices. This call for projects aims to award funding and mentorship to selected projects through the MDS III accelerator program. Proposals will be accepted until July 9th, 2021 via the online application form.
Company Info
Location
paris, ile de france, france
Additional Info
MD START : Transforming innovative ideas into medical realities. A team of medtech serial entrepreneurs with both strategic and hands-on operational experience creating European medtech companies: Leveraging a rich tradition of European medtech innovation, incubating life-changing technologies, running companies which would not otherwise exist, increasing value through a capital efficient model and strategic alignment with our corporate investors. MD Start is a unique opportunity to invest alongside large medtech players and a financial investor with a proven track record. Invest very early in the value creation chain, with significant potential return-on-investment. CULTIVATING MEDTECH INNOVATION : MD Start is a incubator, a team of entrepreneurs and a fund brought together under the same efficient 3-in-1. MD Start II is not another fund and is not another incubator: MD Start is the entrepreneur as well as the incubator and the investor. From its proprietary deal flow originating from physician and researcher inventors, MD Start creates, develops and operates the projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.